<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Acta Biochim. Pol</journal-id>
<journal-title>Acta Biochimica Polonica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Acta Biochim. Pol</abbrev-journal-title>
<issn pub-type="epub">1734-154X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">13126</article-id>
<article-id pub-id-type="doi">10.3389/abp.2024.13126</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Science archive</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Understanding mitochondrial potassium channels: 33 years after discovery</article-title>
<alt-title alt-title-type="left-running-head">Szewczyk</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/abp.2024.13126">10.3389/abp.2024.13126</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Szewczyk</surname>
<given-names>Adam</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1303629/overview"/>
</contrib>
</contrib-group>
<aff>
<institution>Laboratory of Intracellular Ion Channels</institution>, <institution>Nencki Institute of Experimental Biology</institution>, <institution>Polish Academy of Sciences</institution>, <addr-line>Warsaw</addr-line>, <country>Poland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/31488/overview">Grzegorz Wegrzyn</ext-link>, University of Gdansk, Poland</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2720226/overview">Agata Wawrzkiewicz-Ja&#x142;owiecka</ext-link>, Silesian University of Technology, Poland</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2722053/overview">Martin Jab&#x16f;rek</ext-link>, Academy of Sciences of the Czech Republic (ASCR), Czechia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2719729/overview">Dominika Mali&#x144;ska</ext-link>, Polish Academy of Sciences, Poland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Adam Szewczyk, <email>a.szewczyk@nencki.edu.pl</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>71</volume>
<elocation-id>13126</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>04</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Szewczyk.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Szewczyk</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Mitochondrial investigations have extended beyond their traditional functions, covering areas such as ATP synthesis and metabolism. Mitochondria are now implicated in new functional areas such as cytoprotection, cellular senescence, tumor function and inflammation. The basis of these new areas still relies on fundamental biochemical/biophysical mitochondrial functions such as synthesis of reactive oxygen species, mitochondrial membrane potential, and the integrity of the inner mitochondrial membrane i.e., the passage of various molecules through the mitochondrial membranes. In this view transport of potassium cations, known as the potassium cycle, plays an important role. It is believed that K<sup>&#x2b;</sup> influx is mediated by various potassium channels present in the inner mitochondrial membrane. In this article, we present an overview of the key findings and characteristics of mitochondrial potassium channels derived from research of many groups conducted over the past 33&#xa0;years. We propose a list of six fundamental observations and most important ideas dealing with mitochondrial potassium channels. We also discuss the contemporary challenges and future prospects associated with research on mitochondrial potassium channels.</p>
</abstract>
<kwd-group>
<kwd>mitochondria</kwd>
<kwd>potassium channels</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>cytoprotection</kwd>
<kwd>potassium channel openers</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>When investigating the fundamentals of mitochondrial function within cells, we can identify several simple cations that form the basis of many processes (<xref ref-type="bibr" rid="B48">Szabo and Zoratti, 2014</xref>). It is well known that the proton gradient serves as the driving force for ATP synthesis in mitochondria. The Ca<sup>2&#x2b;</sup> cations entering the mitochondria not only buffer the cytosolic pool of these ions but can also contribute to some physiological situations such as the mitochondrial mega-channel activation (<xref ref-type="bibr" rid="B8">Carraro and Bernardi, 2023</xref>; <xref ref-type="bibr" rid="B63">Zoratti et al., 2024</xref>). The effects of Mg<sup>2&#x2b;</sup> on mitochondrial functions such as energy metabolism, mitochondrial Ca<sup>2&#x2b;</sup> handling, and apoptosis are well established (<xref ref-type="bibr" rid="B34">Liu and Dudley, 2020</xref>). Mitochondrial Na<sup>&#x2b;</sup> have been discovered as a new second messenger regulating inner mitochondrial membrane (IMM) fluidity and reactive oxygen species (ROS) generation by respiratory chain complex III (<xref ref-type="bibr" rid="B18">Hernansanz-Agust&#xed;n and Enr&#xed;quez, 2022</xref>). In this study, we will focus on the properties and the role of K<sup>&#x2b;</sup> transport, via potassium channels (mitoK channels) present in IMM (<xref ref-type="bibr" rid="B49">Szewczyk, 1996</xref>; <xref ref-type="bibr" rid="B20">Kicinska et al., 2000</xref>; <xref ref-type="bibr" rid="B12">Debska et al., 2001</xref>; <xref ref-type="bibr" rid="B40">O&#x2019;Rourke, 2007</xref>; <xref ref-type="bibr" rid="B45">Singh et al., 2012</xref>; <xref ref-type="bibr" rid="B47">Szabo and Szewczyk, 2023</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Potassium channels identified in the inner mitochondrial membrane. All these types of channels were described in the manuscript. Additionally, the biophysical role in mitochondria and physiological role within the cell is summarized. VDAC, voltage dependent anion channel (porin).</p>
</caption>
<graphic xlink:href="abp-71-13126-g001.tif"/>
</fig>
<p>In general, proper mitochondrial function is based on the integrity of mitochondrial membranes. Peter Mitchell in his Nobel Lecture delivered in 1978 underlined the importance of the low permeability of the IMM to ions (<xref ref-type="bibr" rid="B38">Mitchell, 1985</xref>). Consequently, the discovery of multiple potassium channels in the IMM was for many years considered to be an experimental artifact. Nowadays, mitoK channels present in the IMM are recognized as crucial players for regulating some mitochondrial function (<xref ref-type="bibr" rid="B24">Kravenska et al., 2021</xref>; <xref ref-type="bibr" rid="B47">Szabo and Szewczyk, 2023</xref>). The mitoK channels have attracted attention for many years, especially in the context of the regulation of life/death processes in the various cell types (<xref ref-type="bibr" rid="B15">Garlid, 2000</xref>). For example, the activation of mitoK channels may induce cytoprotective phenomena in cardiac tissue and in neurons (<xref ref-type="bibr" rid="B40">O&#x2019;Rourke, 2007</xref>). On the contrary, inhibition of mitoK channels may cause cell death (<xref ref-type="bibr" rid="B9">Checchetto et al., 2021</xref>).</p>
<p>In this paper, we will present what we consider to be the most significant discoveries/ideas in the field of mitoK channels over the past 33&#xa0;years. These subjective, proposed by author, list of six the most important observations are as follows: 1). Discovery of mitoK channels in various tissues and identification of their molecular identity; 2). Cytoprotection (cardioprotection, neuroprotection) induced by mitoK channels activation; 3). Cancer cell death by mitoK channels inhibition; 4). Role of mitoK channels in aging/senescence/life span; 5). Interactions of mitoK channels with respiratory chain; 6). Druggability of the mitoK channels.</p>
</sec>
<sec id="s2">
<title>Mitochondrial potassium channel discovery</title>
<p>In 1991, an ion channel selective for K<sup>&#x2b;</sup> was discovered in the IMM of rat liver mitochondria (<xref ref-type="bibr" rid="B19">Inoue et al., 1991</xref>), confirming previous findings on channels in mitochondria by Catia Sorgato (<xref ref-type="bibr" rid="B46">Sorgato et al., 1987</xref>). However, what significantly altered the interpretation of this experimental data was the revelation that the channel exhibited not only K<sup>&#x2b;</sup> selectivity but also susceptibility to inhibition by ATP and the antidiabetic sulfonylurea, glibenclamide (<xref ref-type="bibr" rid="B19">Inoue et al., 1991</xref>). This discovery situated mitoK channels within a similar family to ATP-regulated potassium channels found in the plasma membrane of pancreatic beta-cells, cardiomyocytes, neurons, and others (<xref ref-type="bibr" rid="B49">Szewczyk, 1996</xref>; <xref ref-type="bibr" rid="B40">O&#x2019;Rourke, 2007</xref>). Undoubtedly, this observation served as a pivotal starting point for numerous experiments identifying ATP-regulated mitochondrial potassium (mitoK<sub>ATP</sub>) channels across various tissues, notably cardiomyocytes (<xref ref-type="bibr" rid="B51">Szewczyk et al., 2009</xref>; <xref ref-type="bibr" rid="B47">Szabo and Szewczyk, 2023</xref>). Following several years of intensive investigation across multiple laboratories into the functional role of these channels, it was demonstrated that the activation of mitoK<sub>ATP</sub> channels (by potassium channel openers) induces a cardioprotective phenomenon (<xref ref-type="bibr" rid="B35">Liu et al., 1999</xref>; <xref ref-type="bibr" rid="B15">Garlid, 2000</xref>; <xref ref-type="bibr" rid="B56">Szteyn and Singh, 2020</xref>; <xref ref-type="bibr" rid="B36">Lukowski et al., 2022</xref>). Subsequently, similar findings in neural tissue suggested the involvement of these channels in neuroprotection (<xref ref-type="bibr" rid="B7">Busija et al., 2004</xref>; <xref ref-type="bibr" rid="B4">Bednarczyk, 2009</xref>). In summary, the association of mitoK<sub>ATP</sub> channels with cytoprotection marked a significant milestone in the rapid development of the mitochondrial potassium channel field. Moreover, other mitoK channels (such as large conductance calcium-activated potassium&#x2014;mitoBK<sub>Ca</sub> channels) were later implicated in cytoprotection across various cell types (<xref ref-type="bibr" rid="B62">Xu et al., 2002</xref>). Despite a plethora of observations, however, the biochemical mechanisms underlying these events remain unclear. It is probable that the indirect modulation of ROS generation by mitoK channels (via depolarization of mitochondria) contributes to this phenomenon.</p>
<p>In recent years, researchers have demonstrated that the family of mitoK channels constitutes one of the most numerous classes of mitochondrial channel proteins. They are also present in plants and in simple organisms (<xref ref-type="bibr" rid="B21">Koszela-Piotrowska et al., 2009</xref>; <xref ref-type="bibr" rid="B37">Matkovic et al., 2011</xref>; <xref ref-type="bibr" rid="B30">Laskowski et al., 2015</xref>). It includes not only mitoK<sub>ATP</sub> and mitoBK<sub>Ca</sub> channels but also intermediate conductance (mitoIK<sub>Ca</sub>), and small conductance (mitoSK<sub>Ca</sub>), voltage-regulated potassium (mitoKv1.3, mitoKv7.4) channels, mitochondrial hyperpolarization-activated cyclic nucleotide-gated (mitoHCN) channels, mitochondrial sodium-activated potassium (mitoSlo2) channel and two-pore domain potassium (mitoTASK-3) channel (<xref ref-type="bibr" rid="B47">Szabo and Szewczyk, 2023</xref>). The activity of potassium channels are regulated by various stimuli, such as pH, Ca<sup>2&#x2b;</sup> and ROS (<xref ref-type="bibr" rid="B47">Szabo and Szewczyk, 2023</xref>). The mitoK channels have been identified in many tissues but at the same time their number of molecules in mitochondrial membranes is relatively small compared to other mitochondrial transport proteins. Probably low density of mitoK channels and channel run down phenomenon were reasons for questioning in the 90&#x2019;s the presence of these channels at all.</p>
<p>Another issue regarding mitoK channels is the following: why is such a simple process, like K<sup>&#x2b;</sup> influx into a matrix, facilitated by a wide variety of potassium channels? For example, in cardiac mitochondria, six mitoK channels have been identified: mitoK<sub>ATP</sub>, mitoBK<sub>Ca</sub>, mitoSK<sub>Ca</sub>, mitoSlo2, mitoHCN channels and mitoKv7.4 channels (<xref ref-type="bibr" rid="B47">Szabo and Szewczyk, 2023</xref>). What is the physiological benefit of using many different ligands and factors to regulate these channels? Probably, potassium channels present in cardiomyocyte mitochondria are activated under specific physiological circumstances (<xref ref-type="bibr" rid="B25">Kulawiak et al., 2021</xref>). An early event during cardiac ischemia is ATP depletion. This is followed by mitochondrial membrane depolarization. Moreover, because of ATP depletion, ion pumps cannot function, leading to an increase in the cellular Ca<sup>2&#x2b;</sup> concentration. The rise in Ca<sup>2&#x2b;</sup> during ischemia and reperfusion leads to an overload of mitochondrial Ca<sup>2&#x2b;</sup>, during reperfusion when oxygen is reintroduced. The decrease in intracellular pH during severe ischemia promotes the imbalance of other cations and leading to cellular Na<sup>&#x2b;</sup> overload (<xref ref-type="bibr" rid="B25">Kulawiak et al., 2021</xref>). These complex changes may lead to channel activation/inhibition possibly explains why there are few potassium channels in cardiac mitochondria. Most likely, the timing of ATP, pH, Ca<sup>2&#x2b;</sup>, and Na<sup>&#x2b;</sup> concentration changes is critical to control K<sup>&#x2b;</sup> flux in mitochondria stabilizing structure of mitochondria.</p>
<p>Molecular identity of mitoK channels for many years was a mystery. Lack of molecular mitoK identity was an argument questioning the presence of potassium channels in mitochondria. Let&#x2019;s summarize this long way of channel molecular identity recognition. Today we believe that mitoBK<sub>Ca</sub> channel is one of the splice variants of KCNMA1 (Slo1) gene (<xref ref-type="bibr" rid="B44">Singh et al., 2013</xref>; <xref ref-type="bibr" rid="B14">Galecka et al., 2021</xref>). Properties of mitoBK<sub>Ca</sub> suggest that the pore-forming subunit is encoded by the same gene coding for plasma membrane BK<sub>Ca</sub>. Several studies suggested that the VEDEC BK<sub>Ca</sub> isoform is located in the IMM. With the mitoK<sub>ATP</sub> channel there is a more complex situation. It can not be excluded that K<sup>&#x2b;</sup> influx is catalyzed by 2-3 various proteins in various tissues. Recently, it was shown that the pore-forming subunit of the mitoK<sub>ATP</sub> channel is a product of the CCDC51 gene (<xref ref-type="bibr" rid="B41">Paggio et al., 2019</xref>). The mitoK<sub>ATP</sub> is inhibited by the antidiabetic sulfonylurea glibenclamide. Therefore, it was speculated that the glibenclamide receptor (product of ABC8/MITOSUR gene) is an integral part of the mitoK channel. Indeed the mitoK<sub>ATP</sub> channel formed by these two proteins has the established pharmacological properties of the mitoK<sub>ATP</sub> channel (<xref ref-type="bibr" rid="B41">Paggio et al., 2019</xref>). Previous studies showed that also the ROMK2 potassium channel isoform of the renal outer medullary potassium channel could be the component of the mitoK<sub>ATP</sub> channel (<xref ref-type="bibr" rid="B5">Bednarczyk et al., 2018</xref>; <xref ref-type="bibr" rid="B29">Laskowski et al., 2019</xref>). Detailed discussion on mitochondrial potassium channel molecular identity was recently reviewed (<xref ref-type="bibr" rid="B47">Szabo and Szewczyk, 2023</xref>).</p>
<p>The presence of various auxiliary &#x3b2; subunits in mitoBK<sub>Ca</sub> channels and sulfonylurea receptors in the mitoK<sub>ATP</sub> channel causes that, despite undoubted progress in the identification of channel proteins, the problem of their detailed identification is still a challenge for the future (<xref ref-type="bibr" rid="B42">Piwonska et al., 2008</xref>).</p>
</sec>
<sec id="s3">
<title>From cytoprotection to cell death</title>
<p>The mitoK channels have been described as an important player in cellular pro-life and death signaling. The activation of mitoK channels (by potassium channel openers), such as ATP-regulated or calcium-activated large conductance potassium channels, may have cytoprotective effects in cardiac or neuronal tissue (<xref ref-type="bibr" rid="B35">Liu et al., 1999</xref>; <xref ref-type="bibr" rid="B7">Busija et al., 2004</xref>). This concept was a strong driving force of studies in many laboratories. Potassium channel opener induced cytoprotection is also induced by endogenous signaling via protein kinases (<xref ref-type="bibr" rid="B13">Frankenreiter et al., 2017</xref>).</p>
<p>It has also been shown that inhibition with channel blockers of the mitochondrial Kv1.3 channel may lead to pancreatic cancer cell death (<xref ref-type="bibr" rid="B32">Leanza et al., 2014</xref>). But still there is an open question to what extent mitoK channels are promising drug targets in various organs and tissues? Future prospects of the druggability concept of mitoK channels was evaluated recently (<xref ref-type="bibr" rid="B60">Wrzosek et al., 2020</xref>).</p>
</sec>
<sec id="s4">
<title>Searching for new functions of mitochondrial potassium channels</title>
<p>The putative functional roles of these channels involve alterations in mitochondrial matrix volume, mitochondrial respiration, and protonmotive force (membrane potential) (<xref ref-type="bibr" rid="B11">Czyz et al., 1995</xref>). Furthermore, the activity of these channels influences the generation of ROS by mitochondria (<xref ref-type="bibr" rid="B26">Kulawiak et al., 2008</xref>; <xref ref-type="bibr" rid="B28">Kulawiak et al., 2023</xref>). The activity of mitochondrial potassium channels is subject to modulation by various intrinsic signals, including Ca<sup>2&#x2b;</sup> concentration, membrane potential, phosphorylation, and membrane stretching (<xref ref-type="bibr" rid="B47">Szabo and Szewczyk, 2023</xref>).</p>
<p>It was demonstrated that BK<sub>Ca</sub> channels are present in <italic>Drosophila melanogaster</italic> mitochondria, and channel mutants induce structural and functional defects in mitochondria leading to an increase in ROS (<xref ref-type="bibr" rid="B17">Gururaja Rao et al., 2019</xref>). It was found that the absence of BK<sub>Ca</sub> channels reduced the lifespan of <italic>Drosophila</italic>, and overexpression of human BK<sub>Ca</sub> channels in flies extends their life. This suggested a potential role of mitoK channels and ROS in regulating mitochondrial functional integrity, and lifespan (<xref ref-type="bibr" rid="B17">Gururaja Rao et al., 2019</xref>). Probably mitoBK<sub>Ca</sub> play a role in cellular senescence induced by oxidative stress (<xref ref-type="bibr" rid="B16">Gluchowska et al., 2023</xref>).</p>
</sec>
<sec id="s5">
<title>Mitochondrial context of potassium channel regulation</title>
<p>The mitochondrial respiratory chain comprises a series of complex organized redox reactions generating a protonmotive force and, consequently, ATP synthesis. Certain redox centers, such as complexes I and III of the mitochondrial respiratory chain are sources of ROS. Mitochondrial generated ROS can influence remotely the activity of mitoK channels. But there are some indications proposing an alternative, a direct mechanism for the regulation of mitoK channels by the respiratory chain.</p>
<p>It is well-known that mitoK channels interact with various mitochondrial proteins, some of which are involved in the respiratory chain. These observations were recently summarized (<xref ref-type="bibr" rid="B33">Lewandowska et al., 2024</xref>). For instance, it has been suggested that mitoK<sub>ATP</sub> channels interact with succinate dehydrogenase. In cardiac mitochondria, it was found that the &#x3b2;1 subunit of the mitoBK<sub>Ca</sub> channels interacts with Cytochrome c Oxidase (COX) subunit I. Furthermore, studies have demonstrated that other respiratory chain protein complexes interact with mitoBK<sub>Ca</sub> channels in both cardiac and brain mitochondria. Additionally, mitochondrial tandem pore domain K<sup>&#x2b;</sup> channels TASK-3 interact also with the respiratory chain. A recent report revealed a similar interaction between the mitoKv1.3 channel and respiratory chain complex I (for review see <xref ref-type="bibr" rid="B33">Lewandowska et al., 2024</xref>).</p>
<p>We found that the activity of mitoBK<sub>Ca</sub> channels in glioblastoma cells is regulated by substrates and inhibitors of the respiratory chain (<xref ref-type="bibr" rid="B6">Bednarczyk et al., 2013</xref>). This study suggested that COX is a key element of this kind of channel regulation (<xref ref-type="bibr" rid="B6">Bednarczyk et al., 2013</xref>). Moreover, given that COX is the primary infrared-absorbing protein, it raises questions about the potential light regulation of mitoK channels (<xref ref-type="bibr" rid="B50">Szewczyk and Bednarczyk, 2018</xref>).</p>
<p>Further research will be important to clarify the functional consequences of these interactions. Undoubtedly, this form of regulation may prove to be unique for mitoK channels. The exact nature and functional implications of these interactions remain unclear. This kind of direct functional coupling between the energy generating system (respiratory chain) with the energy dissipation system (potassium channels) may lead to an interesting putative regulatory mechanism in mitochondria.</p>
<p>Recently other functional/structural coupling within the mitochondrial potassium channel was observed. It was found that mitochondrial potassium channel ROMK2 may interact with two lipid kinases: acylglycerol kinase (AGK) and diacylglycerol kinase &#x3b5; (DGKE), which are localized in mitochondria (<xref ref-type="bibr" rid="B23">Krajewska et al., 2024</xref>). Additionally, it was found that the products of AGK and DGKE, lysophosphatidic acid (LPA) and phosphatidic acid (PA), stimulated the activity of ROMK2 potassium channels reconstituted in planar lipid bilayers (<xref ref-type="bibr" rid="B23">Krajewska et al., 2024</xref>).</p>
<p>The structure/function interplay of mitoK channels alongside other mitochondrial proteins suggests a new dimension in mitoK channels regulation. The exceptionally high membrane potential of the IMM and its potential for ROS generation may characterize significant signaling pathways within cells.</p>
</sec>
<sec id="s6">
<title>The troublesome pharmacology of mitochondrial potassium channels</title>
<p>In order to influence activity of various mitoK channels, numerous research groups continually explore novel compounds hoping to find molecules with high specificity for mitoK channels (<xref ref-type="bibr" rid="B53">Szewczyk and Marban, 1999</xref>; <xref ref-type="bibr" rid="B1">Augustynek et al., 2017</xref>; <xref ref-type="bibr" rid="B31">Leanza et al., 2019</xref>). The existing literature already reports positive protective effects on ischemia/reperfusion processes through the activation of mitoK<sub>ATP</sub> channels by the potassium channel opener - diazoxide, and the mitoBK<sub>Ca</sub> channels by potassium channel opener NS1619 and its follower NS11021 (<xref ref-type="bibr" rid="B54">Szewczyk et al., 2006</xref>). Nevertheless, it is noteworthy that these compounds exhibit limited specificity towards mitoK channels. Application of these substances in the micromolar concentration range unmasks a variety of side effects (<xref ref-type="bibr" rid="B61">Wrzosek et al., 2022</xref>). It is important to remember that molecules with some hydrophobicity of positive charge (in physiological pH) will be accumulated by mitochondria. It is due to very high membrane potential (up to&#x2014;180&#xa0;mV) on the IMM, with negative polarization of the mitochondrial matrix. For example, a 10&#xa0;nM drug present in cytosol could accumulate up to 10&#xa0;&#xb5;M concentration in a matrix (<xref ref-type="bibr" rid="B22">Kowaltowski and Adbulkader, 2024</xref>). At this concentration range the probability of nonspecific interaction with some of &#x223c;1,500 mitochondrial proteins is very high. In contrast, toxins isolated from the venom of various scorpion species such as iberiotoxin specifically (at low concentration) inhibit the activity of mitoBK<sub>Ca</sub> channels (<xref ref-type="bibr" rid="B1">Augustynek et al., 2017</xref>). But application of this peptide to block mitoBK<sub>Ca</sub> channels on intact cells is practically impossible.</p>
<p>Developing very selective channel blockers and potassium channel openers targeting mitoK channels is a significant challenge in this field. Recently it was shown that selective targeting of mitoIK<sub>Ca</sub> channel (<xref ref-type="bibr" rid="B3">Bachmann et al., 2022</xref>), mitoTASK channel (<xref ref-type="bibr" rid="B2">Bachmann et al., 2021</xref>) and mitoKv channel (<xref ref-type="bibr" rid="B43">Severin et al., 2022</xref>) is possible.</p>
</sec>
<sec sec-type="discussion" id="s7">
<title>Discussion</title>
<p>Over the past 33&#xa0;years since the identification of the first potassium channel in the IMM, research in this field has made significant progress (<xref ref-type="bibr" rid="B27">Kulawiak and Szewczyk, 2022</xref>). This pathway started from identification of the mitoK channels that met with skepticism by the bioenergetics community to current research placing these channels in the phenomena of cytoprotection, cellular senescence, and neoplastic cell death. What limits further development of this field?</p>
<p>First, access to good pharmacology is the &#x201c;dark side&#x201d; of this field (<xref ref-type="bibr" rid="B52">Szewczyk et al., 2010</xref>; <xref ref-type="bibr" rid="B39">Olszewska and Szewczyk, 2013</xref>; <xref ref-type="bibr" rid="B31">Leanza et al., 2019</xref>). Because mitoK channels are similar to those located in plasma membranes, it is very difficult to identify pharmacological modulators specific only for mitoK channels (<xref ref-type="bibr" rid="B55">Szewczyk and Wojtczak, 2002</xref>; <xref ref-type="bibr" rid="B10">Citi et al., 2018</xref>). The unique high membrane potential of mitochondria may help to discriminate targeting of some drugs to mitoK channels (<xref ref-type="bibr" rid="B57">Testai et al., 2015</xref>; <xref ref-type="bibr" rid="B60">Wrzosek et al., 2020</xref>).</p>
<p>The second limiting factor for further progress is the development of new techniques to measure channel activity <italic>in situ</italic>, that is, within an intact cell. Majority of techniques currently applied in the studies are based on cell fractionation and mitochondria isolation (<xref ref-type="bibr" rid="B58">Walewska et al., 2022</xref>). By definition in this process we lose a network of signaling pathways where mitoK channels are potentially involved (<xref ref-type="bibr" rid="B59">Walewska et al., 2018</xref>). Probably progress in synthesis of potassium specific fluorescent probes may solve this problem. Unfortunately, there are other potassium transport proteins in mitochondria.</p>
<p>The third challenge for the future involves further identifying the molecular identity of various mitoK channels. This aim will not only expand our understanding of the system but also will start new avenues of research, such as <italic>in vitro</italic> translation with lipid nanodiscs and the application of various biophysical techniques. Additionally, it will aid in the identification of protein neighborhoods, clarification of the import machinery, and more.</p>
<p>In summary, mitoK channels, considered the &#x201c;younger siblings&#x201d; of the potassium channels found in plasma membranes, play a crucial role in some cellular signaling pathways. The mitoK location within mitochondria, which serve as hubs for fundamental metabolic and signaling functions, highlight their significance. The author believes that the future of this field holds exciting prospects.</p>
</sec>
</body>
<back>
<sec id="s8">
<title>Author contributions</title>
<p>The author confirms being the sole contributor of this work and has approved it for publication.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Supported by the Polish National Science Centre (MAESTRO grant No. 2019/34/A/NZ1/00352).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ack>
<p>This article is dedicated to Prof. Lech Wojtczak (Nencki Institute of Experimental Biology, Warsaw), whose teachings have greatly contributed to my understanding of mitochondria, and to Prof. Michel Lazdunski (Institute of Molecular and Cellular Pharmacology CNRS, Sophia Antipolis), who introduced me to potassium channels.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Augustynek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kunz</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Guide to the pharmacology of mitochondrial potassium channels</article-title>. <source>Handb. Exp. Pharmacol.</source> <volume>240</volume>, <fpage>103</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1007/164_2016_79</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bachmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rossa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Antoniazzi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Biasutto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Carrer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Campagnaro</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3</article-title>. <source>Pharmacol. Res.</source> <volume>164</volume>, <fpage>105326</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2020.105326</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bachmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rossa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Varanita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fioretti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Biasutto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Milenkovic</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis <italic>in vivo</italic>
</article-title>. <source>Cell death Dis.</source> <volume>13</volume> (<issue>12</issue>), <fpage>1055</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-022-05463-8</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Potassium channels in brain mitochondria</article-title>. <source>Acta Biochim. Pol.</source> <volume>56</volume>, <fpage>385</fpage>&#x2013;<lpage>392</lpage>. <pub-id pub-id-type="doi">10.18388/abp.2009_2471</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kicinska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Laskowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kampa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Walewska</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Evidence for a mitochondrial ATP-regulated potassium channel in human dermal fibroblasts</article-title>. <source>Biochim. Biophys. Acta Bioenerg.</source> <volume>1859</volume>, <fpage>309</fpage>&#x2013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2018.02.005</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wieckowski</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Broszkiewicz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Skowronek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Siemen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Putative structural and functional coupling of the mitochondrial BKCa channel to the respiratory chain</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>6</issue>), <fpage>e68125</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0068125</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busija</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Lacza</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Rajapakse</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bari</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Targeting mitochondrial ATP-sensitive potassium channels--a novel approach to neuroprotection</article-title>. <source>Brain Res. Rev.</source> <volume>46</volume>, <fpage>282</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2004.06.011</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carraro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The mitochondrial permeability transition pore in Ca<sup>2&#x2b;</sup> homeostasis</article-title>. <source>Cell calcium</source> <volume>111</volume>, <fpage>102719</fpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2023.102719</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Checchetto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Leanza</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>De Stefani</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rizzuto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gulbins</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mitochondrial K<sup>&#x2b;</sup> channels and their implications for disease mechanisms</article-title>. <source>Pharmacol. Ther.</source> <volume>227</volume>, <fpage>107874</fpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2021.107874</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Citi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Calderone</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Breschi</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Testai</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Pathophysiological role of mitochondrial potassium channels and their modulation by drugs</article-title>. <source>Curr. Med. Chem.</source> <volume>25</volume> (<issue>23</issue>), <fpage>2661</fpage>&#x2013;<lpage>2674</lpage>. <pub-id pub-id-type="doi">10.2174/0929867324666171012115300</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Czyz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nalecz</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Wojtczak</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>The role of mitochondrial potassium fluxes in controlling the protonmotive force in energized mitochondria</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>210</volume>, <fpage>98</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1995.1632</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Debska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kici&#x144;ska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Skalska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Intracellular potassium and chloride channels: An update</article-title>. <source>Acta. Biochim. Pol.</source> <volume>48</volume>, <fpage>137</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.18388/abp.2001_5120</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frankenreiter</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kniess</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>N. I.</given-names>
</name>
<name>
<surname>Straubinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Koprowski</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>cGMP-elevating compounds and ischemic conditioning provide cardioprotection against ischemia and reperfusion injury via cardiomyocyte-specific BK channels</article-title>. <source>Circulation</source> <volume>136</volume>, <fpage>2337</fpage>&#x2013;<lpage>2355</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.028723</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ga&#x142;ecka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Single channel properties of mitochondrial large conductance potassium channel formed by BK-VEDEC splice variant</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>10925</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-90465-3</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garlid</surname>
<given-names>K. D.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Opening mitochondrial K(ATP) in the heart--what happens, and what does not happen</article-title>. <source>Basic Res. Cardiol.</source> <volume>95</volume>, <fpage>275</fpage>&#x2013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1007/s003950070046</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#x142;uchowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kalenik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wrzosek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Lack of activity of the mitochondrial large-conductance calcium-regulated potassium channels in senescent vascular smooth muscle cells</article-title>. <source>Mech. Ageing Dev.</source> <volume>215</volume>, <fpage>111871</fpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2023.111871</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gururaja Rao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Towheed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Karekar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ponnalagu</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>BK<sub>Ca</sub> (<italic>slo</italic>) channel regulates mitochondrial function and lifespan in <italic>Drosophila melanogaster</italic>
</article-title>. <source>Cells</source> <volume>8</volume>, <fpage>945</fpage>. <pub-id pub-id-type="doi">10.3390/cells8090945</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernansanz-Agust&#xed;n</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Enr&#xed;quez</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Sodium in mitochondrial redox signaling</article-title>. <source>Antioxidants Redox Signal.</source> <volume>37</volume>, <fpage>290</fpage>&#x2013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2021.0262</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nagase</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kishi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Higuti</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>ATP-sensitive K<sup>&#x2b;</sup> channel in the mitochondrial inner membrane</article-title>. <source>Nature</source> <volume>352</volume>, <fpage>244</fpage>&#x2013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1038/352244a0</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kicinska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>D bska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kunz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Mitochondrial potassium and chloride channels</article-title>. <source>Acta Biochim. Pol.</source> <volume>47</volume>, <fpage>541</fpage>&#x2013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.18388/abp.2000_3977</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koszela-Piotrowska</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Matkovic</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jarmuszkiewicz</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>A large-conductance calcium-activated potassium channel in potato (Solanum tuberosum) tuber mitochondria</article-title>. <source>Biochem. J.</source> <volume>424</volume>, <fpage>307</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20090991</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kowaltowski</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Abdulkader</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>How and when to measure mitochondrial inner membrane potentials</article-title>. <source>Biophysical J.</source> <volume>S0006-3495</volume> (<issue>24</issue>), <fpage>00176</fpage>&#x2013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2024.03.011</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krajewska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mo&#x17c;ajew</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Filipek</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koprowski</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Interaction of ROMK2 channel with lipid kinases DGKE and AGK: potential channel activation by localized anionic lipid synthesis</article-title>. <source>Biochim. Biophys. Acta Mol. Cell Biol. Lipids</source> <volume>1869</volume>, <fpage>159443</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2023.159443</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kravenska</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Checchetto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Routes for potassium ions across mitochondrial membranes: a biophysical point of view with special focus on the ATP-sensitive K<sup>&#x2b;</sup> channel</article-title>. <source>Biomolecules.</source> <volume>11</volume>, <fpage>1172</fpage>. <pub-id pub-id-type="doi">10.3390/biom11081172</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Multidimensional regulation of cardiac mitochondrial potassium channels</article-title>. <source>Cells</source> <volume>10</volume>, <fpage>1554</fpage>. <pub-id pub-id-type="doi">10.3390/cells10061554</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kudin</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kunz</surname>
<given-names>W. S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>BK channel openers inhibit ROS production of isolated rat brain mitochondria</article-title>. <source>Exp. Neurol.</source> <volume>212</volume>, <fpage>543</fpage>&#x2013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.05.004</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Current challenges of mitochondrial potassium channel research</article-title>. <source>Front. Physiol.</source> <volume>13</volume>, <fpage>907015</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2022.907015</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>&#x17b;ochowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Galuba</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stroud</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Loss of the large conductance calcium-activated potassium channel causes an increase in mitochondrial reactive oxygen species in glioblastoma cells</article-title>. <source>Pflugers Arch.</source> <volume>475</volume>, <fpage>1045</fpage>&#x2013;<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-023-02833-9</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laskowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Augustynek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>&#x17b;ochowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kalisz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>O&#x27;Rourke</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Single-Channel properties of the ROMK-pore-forming subunit of the mitochondrial ATP-sensitive potassium channel</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume>, <fpage>5323</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20215323</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laskowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kicinska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jarmuszkiewicz</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Mitochondrial large-conductance potassium channel from <italic>Dictyostelium discoideum</italic>
</article-title>. <source>Int. J. Biochem. Cell Biol.</source> <volume>60</volume>, <fpage>167</fpage>&#x2013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2015.01.006</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leanza</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Checchetto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Biasutto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rossa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bachmann</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Pharmacological modulation of mitochondrial ion channels</article-title>. <source>Br. J. Pharmacol.</source> <volume>176</volume> (<issue>22</issue>), <fpage>4258</fpage>&#x2013;<lpage>4283</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14544</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leanza</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zoratti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gulbins</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Mitochondrial ion channels as oncological targets</article-title>. <source>Oncogene</source> <volume>33</volume>, <fpage>5569</fpage>&#x2013;<lpage>5581</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2013.578</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewandowska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kalenik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wrzosek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Redox regulation of mitochondrial potassium channels activity</article-title>. <source>Antioxidants</source> <volume>13</volume>, <fpage>434</fpage>. <pub-id pub-id-type="doi">10.3390/antiox13040434</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dudley</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Magnesium, oxidative stress, inflammation, and cardiovascular disease</article-title>. <source>Antioxidants</source> <volume>9</volume>, <fpage>907</fpage>. <pub-id pub-id-type="doi">10.3390/antiox9100907</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Seharaseyon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>O&#x27;Rourke</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Marb&#xe1;n</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Mitochondrial ATP&#x2010;dependent potassium channels: viable candidate effectors of ischemic preconditioning<sup>a</sup>
</article-title>. <source>Ann. N. Y. Acad. Sci.</source> <volume>874</volume>, <fpage>27</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1999.tb09222.x</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukowski</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cruz Santos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuret</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ruth</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>cGMP and mitochondrial K&#x2b; channels-Compartmentalized but closely connected in cardioprotection</article-title>. <source>Br. J. Pharmacol.</source> <volume>179</volume>, <fpage>2344</fpage>&#x2013;<lpage>2360</lpage>. <pub-id pub-id-type="doi">10.1111/bph.15536</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matkovic</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Koszela-Piotrowska</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Jarmuszkiewicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Ion conductance pathways in potato tuber (Solanum tuberosum) inner mitochondrial membrane</article-title>. <source>Biochim. Biophys. Acta.</source> <volume>1807</volume>, <fpage>275</fpage>&#x2013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2010.12.001</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>The correlation of chemical and osmotic forces in biochemistry</article-title>. <source>J. Biochem.</source> <volume>97</volume>, <fpage>1</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a135033</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olszewska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mitochondria as a pharmacological target: Magnum overview</article-title>. <source>IUBMB Life</source> <volume>65</volume>, <fpage>273</fpage>&#x2013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1002/iub.1147</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;Rourke</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Mitochondrial ion channels</article-title>. <source>Annu. Rev. Physiol.</source> <volume>69</volume>, <fpage>19</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.69.031905.163804</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paggio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Checchetto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Campo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Menab&#xf2;</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Di Marco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Di Lisa</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Identification of an ATP-sensitive potassium channel in mitochondria</article-title>. <source>Nature</source> <volume>572</volume>, <fpage>609</fpage>&#x2013;<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1498-3</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piwonska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wilczek</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilczynski</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Differential distribution of Ca<sup>2&#x2b;</sup>-activated potassium channel beta4 subunit in rat brain: Immunolocalization in neuronal mitochondria</article-title>. <source>Neuroscience</source> <volume>153</volume>, <fpage>446</fpage>&#x2013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.01.050</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Severin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Urbani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Varanita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bachmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Azzolini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martini</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis <italic>in vivo</italic> in a genetic CLL model</article-title>. <source>J. Exp. Clin. cancer Res.</source> <volume>41</volume> (<issue>1</issue>), <fpage>64</fpage>. <pub-id pub-id-type="doi">10.1186/s13046-022-02249-w</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bopassa</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Meredith</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Stefani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Toro</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>MitoBK(Ca) is encoded by the Kcnma1 gene, and a splicing sequence defines its mitochondrial location</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>110</volume>, <fpage>10836</fpage>&#x2013;<lpage>10841</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1302028110</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stefani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Toro</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Intracellular BK(Ca) (iBK(Ca)) channels</article-title>. <source>J. Physiology</source> <volume>590</volume>, <fpage>5937</fpage>&#x2013;<lpage>5947</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2011.215533</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorgato</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>B. U.</given-names>
</name>
<name>
<surname>St&#xfc;hmer</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Patch-clamping of the inner mitochondrial membrane reveals a voltage-dependent ion channel</article-title>. <source>Nature</source> <volume>330</volume>, <fpage>498</fpage>&#x2013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/330498a0</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szabo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Mitochondrial ion channels</article-title>. <source>Annu. Rev. Biophys.</source> <volume>52</volume>, <fpage>229</fpage>&#x2013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biophys-092622-094853</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szabo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zoratti</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Mitochondrial channels: Ion fluxes and more</article-title>. <source>Physiol. Rev.</source> <volume>94</volume>, <fpage>519</fpage>&#x2013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00021.2013</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>The ATP-regulated K<sup>&#x2b;</sup> channel in mitochondria: Five years after its discovery</article-title>. <source>Acta Biochim. Pol.</source> <volume>43</volume>, <fpage>713</fpage>&#x2013;<lpage>719</lpage>. <pub-id pub-id-type="doi">10.18388/abp.1996_4469</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Modulation of the mitochondrial potassium channel activity by infrared light</article-title>. <source>Biophysical J.</source> <volume>114</volume>, <fpage>43a</fpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2017.11.288</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jarmuszkiewicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kunz</surname>
<given-names>W. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Mitochondrial potassium channels</article-title>. <source>IUBMB Life</source> <volume>61</volume>, <fpage>134</fpage>&#x2013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1002/iub.155</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kajma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Malinska</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wrzosek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zab&#x142;ocka</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Pharmacology of mitochondrial potassium channels: Dark side of the field</article-title>. <source>FEBS Lett.</source> <volume>584</volume>, <fpage>2063</fpage>&#x2013;<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2010.02.048</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marb&#xe1;n</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Mitochondria: A new target for K channel openers?</article-title> <source>Trends Pharmacol. Sci.</source> <volume>20</volume>, <fpage>157</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-6147(99)01301-2</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Skalska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>G&#x142;ab</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mali&#x144;ska</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Koszela-Piotrowska</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Mitochondrial potassium channels: From pharmacology to function</article-title>. <source>Biochim. Biophys. Acta.</source> <volume>1757</volume>, <fpage>715</fpage>&#x2013;<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2006.05.002</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wojtczak</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Mitochondria as a pharmacological target</article-title>. <source>Pharmacol. Rev.</source> <volume>54</volume>, <fpage>101</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1124/pr.54.1.101</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szteyn</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>BKCa channels as targets for cardioprotection</article-title>. <source>Antioxidants</source> <volume>9</volume>, <fpage>760</fpage>. <pub-id pub-id-type="doi">10.3390/antiox9080760</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Testai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rapposelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Breschi</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Calderone</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Mitochondrial potassium channels as pharmacological target for cardioprotective drugs</article-title>. <source>Med. Res. Rev.</source> <volume>35</volume>, <fpage>520</fpage>&#x2013;<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1002/med.21332</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walewska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krajewska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stefanowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Buta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bilewicz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Krysi&#x144;ski</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Methods of measuring mitochondrial potassium channels: a critical assessment</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>, <fpage>1210</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23031210</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walewska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koprowski</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Gas signaling molecules and mitochondrial potassium channels</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume>, <fpage>3227</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19103227</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wrzosek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Augustynek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>&#x17b;ochowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Szewczyk</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mitochondrial potassium channels as druggable targets</article-title>. <source>Biomolecules</source> <volume>10</volume>, <fpage>1200</fpage>. <pub-id pub-id-type="doi">10.3390/biom10081200</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wrzosek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ga&#x142;ecka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>&#x17b;ochowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Olszewska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kulawiak</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Alternative targets for modulators of mitochondrial potassium channels</article-title>. <source>Molecules</source> <volume>27</volume>, <fpage>299</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27010299</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Van Eyk</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Sidor</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Cytoprotective role of Ca<sup>2&#x2b;</sup>- activated K<sub>&#x2b;</sub> channels in the cardiac inner mitochondrial membrane</article-title>. <source>Science</source> <volume>298</volume>, <fpage>1029</fpage>&#x2013;<lpage>1033</lpage>. <pub-id pub-id-type="doi">10.1126/science.1074360</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoratti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Biasutto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Parrasia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Mitochondrial permeability transition pore: A snapshot of a therapeutic target</article-title>. <source>Expert Opin. Ther. Targets</source> <volume>28</volume>, <fpage>1</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1080/14728222.2024.2306337</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>